SuzanneConzenMD

PubMed

• Expression of Glucocorticoid Receptor Is Associated with Aggressive Primary Endometrial Cancer and Increases from Primary to Metastatic Lesions
  Gini F Fleming, Suzanne D Conzen, Jennifer Taylor Veneris> ;Gynecologic Oncology. 2017 Sep 21
• MRI reveals increased tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer.
  Mustafi, D.,Fernandez, S.,Markiewicz, E.,Fan, X.,Zamora, M.,Mueller, J.,Brady, M. J.,Conzen, S. D.,Karczmar, G. S.> ;NMR Biomed. 1900 Jan 01
• 70 citations
  GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome
  Diana C. West, Deng Pan, Eva Tonsing-Carter, Kyle M. Hernandez, Charles F. Pierce, Sarah C. Styke, Kathleen R. Bowie, Tzintzuni Garcia, Masha Kocherginsky, Suzanne D. ...> ;Molecular Cancer Research. 2016 Aug 1
• 16 citations
  Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
  Abena S. Agyeman, Wesley J. Jun, David A. Proia, Caroline R. Kim, Maxwell N. Skor, Masha Kocherginsky, Suzanne D. Conzen> ;Hormones & Cancer. 2016 Feb 8
• 56 citations
  Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
  Erica Stringer-Reasor, Gabrielle M. Baker, Maxwell N. Skor, Masha Kocherginsky, Ernst Lengyel, Gini F. Fleming, Suzanne D. Conzen> ;Gynecologic Oncology. 2015 Sep 1
• 9 citations
  Mammary cancer initiation and progression studied with magnetic resonance imaging
  Xiaobing Fan, Devkumar Mustafi, Erica Markiewicz, Marta Zamora, James Vosicky, Abby Leinroth, Jeffrey Mueller, Kay F. Macleod, Suzanne D. Conzen, Gregory S. Karczmar> ;Breast Cancer Research. 2014 Dec 16
• Join now to see all